Skip to main content
Fig. 3 | Implementation Science

Fig. 3

From: Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda

Fig. 3

3HP Options Trial study procedures and timeline. Patients are screened, consented, randomized, and followed up for up to 15 months following study enrollment. Study staff facilitate all enrollment procedures at baseline, intermittent surveys, and interviews with selected patients during 3HP treatment and the end-of-study visit at 15 months. Patient interactions during and following 3HP treatment including 3HP dosing and monitoring for side effects are otherwise managed by routine Mulago HIV/AIDS clinic staff through the end of patient follow-up

Back to article page